
    
      During the treatment period, rATG is administered at a dose of 1.97 mg/kg/day for 9 days by
      slow intravenous infusion. CSA is administered orally at a dose of 3 mg/kg qod, and
      Levamisole was administered orally at a dose of 2.5 mg/kg qod. The CSA and Levamisole (LMS)
      is designed to alternately every other day.
    
  